For more than a decade, the biological roles and the apparent redundancy of the cytokines tumor necrosis factor (TNF) and lymphotoxin (LT) have been debated. LTo~ exists in its soluble form as a homotrimer, which like TNF only binds the TNF receptors, TNF-R55 or TNF-R75. The cell surface form of LT exists as a heteromer of LTot and LT[3 subunits and this complex specifically binds the LT[3 receptor . To discriminate the functions of the LT and TNF systems, soluble LT[3-R-immunoglobulin (Ig) or TNF-R-Ig fusion proteins were introduced into embryonic circulation by injecting pregnant mice. Exposure to LT[3-R-Ig during gestation disrupted lymph node development and splenic architecture in the progeny indicating that both effects are mediated by the surface LTot/[3 complex. These data are the first to identify a cell surface ligand involved in immune organ morphogenesis. Moreover, they unambiguously discriminate the functions of the various TNF/LT ligands, provide a unique model to study compartmentalization of immune responses and illustrate the generic utility of receptorIg fusion proteins for dissecting/ordering ontogenetic events in the absence of genetic modifications.
Summary
For more than a decade, the biological roles and the apparent redundancy of the cytokines tumor necrosis factor (TNF) and lymphotoxin (LT) have been debated. LTo~ exists in its soluble form as a homotrimer, which like TNF only binds the TNF receptors, TNF-R55 or TNF-R75. The cell surface form of LT exists as a heteromer of LTot and LT[3 subunits and this complex specifically binds the LT[3 receptor (LT [3-R) . To discriminate the functions of the LT and TNF systems, soluble LT[3-R-immunoglobulin (Ig) or TNF-R-Ig fusion proteins were introduced into embryonic circulation by injecting pregnant mice. Exposure to LT[3-R-Ig during gestation disrupted lymph node development and splenic architecture in the progeny indicating that both effects are mediated by the surface LTot/ [3 complex . These data are the first to identify a cell surface ligand involved in immune organ morphogenesis. Moreover, they unambiguously discriminate the functions of the various TNF/LT ligands, provide a unique model to study compartmentalization of immune responses and illustrate the generic utility of receptorIg fusion proteins for dissecting/ordering ontogenetic events in the absence of genetic modifications.
T NF, lymphotoxin (LT)¥~, and LT[3 are members of the TNF superfamily (1) . While TNF is expressed by many cell types, LToL is basically restricted to activated lymphocytes. Both molecules can be secreted as homotrimers, yet TNF also exists as a cell surface homotrimer retained by a transmembrane domain. LTet (also called TNF [3) and TNF homotrimers bind and signal via either of two TNF receptors, TNF-R55 or TNF-R75, to mediate host defense processes (1, 2) . Unlike LTot, LT[3 has not been detected in a secreted form nor as a homotfimer, rather, LT[3 as a type II integral membrane protein complexes with LT0t to form membrane anchored heteromers (3, 4) . The predominant surface LTot/[3 complex does not bind the TNF receptors, but does bind to a unique receptor termed the LT [3-R (5) . Recent reports have shown that recombinant soluble human LTe¢/[3 complexes bind LT[3-R to mediate cytolysis of a subset of human adenocarcinomas (6) but only inefficiently mediate proinflammatory activities (6a) .
In addition to initiating proinflammatory processes, studies suggest that TNF and LTo~ can regulate immune function directly (7, 8) . For example, in vitro TNF signaling can affect thymocyte proliferation and differentiation, B cell 1Abbrewations used in this paper. GC, germinal centers; LT, lymphotoxln. activation and prohferation, and mixed lymphocyte responses. The direct involvement of LTot in the development/organization of peripheral lymphoid organs was demonstrated using the targeted gene disruption approach. LTot -/-mice lack LNs and Peyer's patches, and their spleens have indistinct follicular marginal zones, T/B cell disorganization, and fail to form germinal centers (GC) (9) (10) (11) . Such effects were not noted in mice lacking TNF-R75 (12) (13) (14) . TNF-R55-deficient mice express more limited alterations, i.e,, the absence of only Peyer's patches (15, 16) , the failure to express MAdCAM-1 on splenic marginal zone cells, and the inability to form GC (8) . Since the TNF-R do not appear to mediate the development of the peripheral lymphoid system, it was postulated that the membrane LTod[3/LT[3-R pathway may regulate LN genesis (9) . Recently, it has been suggested that lymphotoxin mediates "neoorganogensis," a pathologic process mimicking normal lymph node genesis (17) . Restricted expression of LTc~ in the pancreas and kidney of transgenic mice caused inflammation in the target tissue manifested by the induction of LN-like structures within these organs.
To investigate the role of LT~x/[3 and TNF in signaling immune system development, we used a novel strategy. Since human IgGi binds the murine Fc receptor FcRn and crosses the yolk sac (18) , it was considered that introduc-tion of receptor decoys, i.e., soluble receptor human IgG1 fusion proteins during gestation might interfere with developmental processes in the absence of permanent genetic alterations.
mode. The final images are representative of these sections. Staining of sections for MAdCAM-1 expression used mAb MECA 367 (PharMingen) followed by PE-conlugated goat anti-rat IgG (PharMmgen).
Materials and Methods
Animals. Timed pregnant Balb/c mice were purchased from The Jackson Laboratory (Bar Harbor, ME), housed under conventional barrier protection, and handled in accordance with institutional guidelines, tLeceptor-Ig proteins or mAbs were injected i.v. into the tall vein.
Fusion Proteins and Antibodies. Fusion proteins comprised of the extracellular domain of either munne LT[3-R or LFA-3 (which does not bind murine CD2) fused to the hinge, CH2, and CH3 domains of human IgG1 were prepared as described (19, 20) . The murine TNF-R55-IgG 1 was created in a similar manner (Browning, J., manuscript in preparation). The absolute specificity of the human receptors for their ligands has been demonstrated in cellbased assays (6) . In the murine LT system, binding of LT[~-R-Ig requires expression of both LT& and LT [3 proteins (19) . Murine LT[3-P,-Ig fusion protein can inhibit the activity of LTc~/[3 in a mouse LT[3-1L-based cytotoxicity assay in which murine TNF-R55-Ig is inactive. Likewise, the specificity of the interaction of TNF-R55 with LT& has been well-characterized in human systems and we have shown further that both human and mouse TNF-1L55-Ig can block the activity of recombinant murine LTc~ in a TNF-1L55-based cytotoxlcity assay (Mackay, F., and J. Browning, manuscript m preparation). A hamster IgG mAb BBF6 specific for murine LT[3 was prepared by conventional methodology (Browning, J., manuscript in preparation). Anti-LT[3 mAb BBF6 can block munne LT~x/[3 signaling in an LT[3-R-based cytotoxlcity assay (Mackay, F., and J. Browning, manuscript in preparation). Polyclonal hamster IgG (PharMmgen, San Diego, CA) was used as a control.
ELISAs. Analyses for receptor-Is in plasma used mAbs specific for munne LT[3-P, (Browning, J., I. Sizmg, P. Lawton, P. Bourdon, P. R.ennert, G. Majeau, C. Ambrose, C. Hession, K. Miatkowska, D. Grlffiths et al., manuscript in preparation), , or the CH3 domain of human IgG1 (CDG5, prepared at Blogen, Cambridge, MA) directly immobilized (10 I.zg/ml) on 96-well microtiter plates for capture, and donkey anti-human IgGl-horseradish peroxldase for detection (1:4,000 dilutions; Jackson Immunol~e-search Laboratories, West Grove, PA). ELISA for hamster mAbs in plasma used immobilized goat ann-hamster IgG (10 ~g/ml; Southern Biotechnology Associates, Birmingham, AL) for capture, and goat anti-hamster IgG-horseradish peroxidase for detection (1:6,000; Southern Bmtechnology Associates).
Immunohistochemistry. Tissues were fixed in 10% buffered formalin, embedded m paraffin, and sectioned for hematoxylin/ eosin staining. For immunofluorescence staimng, frozen spleen sections were acetone fixed, air dried, and preblocked with 5 I.tg/ml ant1-CD16/CD32 Fc block (PharMingen) in Tris-buffered saline with 0.25% BSA, 0.05% Tween 20, and 10% heat-aggregated rabbit serum. Ceils were stained with 5 b~g/rnl blotinylated anti-B220 mAb 0PharMingen) in the same buffer, followed by 10 I.~g/ml fluorescein conjugated-neutralite (FITC-avidin; Southern Biotechnology Associates) and 5 b~g/ml PE-conlugated anti-CD4 mAb (Pharmingen). Slides were viewed under X 100 optics and separate red and green images, digitized. Each of the images was analyzed with Adobe Photoshop TM in a consistent manner tbllowed by overlaying of the green and red images in the screen
Results and Discussion

Gestational Blockade of L Tc~ / fl Disrupts LN Genesis.
The loss of TNF signaling as revealed by the genetic ablation of murine TNF-R55 leads to defects in the initiation of acute inflammatory cascades, an inability to defend against intracellular parasites, failure to generate GC, and the absence of Peyer's patches (8, (12) (13) (14) 16) . In contrast, mice with a disrupted LT~ gene lack LNs and Peyer's patches, and possess spleens with indistinct follicular marginal zones and T/B cell disorganization (9) (10) (11) . These genetic experiments suggest that disruption of cell surface LTo~/[3 heterommers mediates most aspects of the defects in the LTc¢ knockout mice. To evaluate the role ofmurine LT~x/[3 complexes in the development of the secondary lymphoid organs, the actions of surface LT ligand in the fetus and young mice were blocked by introducing either murine LTI3-R-Ig or mufine TNF-R55-Ig fusion proteins, i.e., soluble receptor decoys, into the fetus via maternal transfer or by direct injection into neonates.
The regimen of fusion protein administration chosen was influenced by (a) the reported time of LN development during rodent embryogenesis (21); (b) in situ hybridization studies showing that LT[3 mlLNA is expressed in thymocytes and lymph nodes (but not spleen) in mouse embryos at day 16.5 of gestation (French, L., J. Tschopp, andJ. Browning, manuscript in preparation); and (c) observations that LT~3-R. message is detected in embryos as early as 7 d after coitus (22) , and is expressed in some epithelial tissues and thymus at day 14.5 of gestation (French, L., J. Tschopp, and J. Browning, manuscript in preparation). Thus, mice were injected i.v. with 200 b~g of fusion protein on days 14 and 17 of gestation, and the progeny were visually inspected for the presence of LNs at various ages. All LNs and Peyer's patches were readily detected in the progeny of mice that received either PBS, LFA-3-Ig, or TNF-R55-Ig. In contrast, inguinal and popliteal LNs and Peyer's patches were absent in the progeny of mice treated with LT[3-1L-Ig (Table 1) . Microscopic examination revealed the presence of juxtaposed lymphatic and circulatory vessels but no anlage of lymphoid organs at the sites where these nodes are usually observed (Fig. 1) . Interestingly, brachial and mesenteric LNs were present in the progeny of mice that had been treated with LT[3-1L on days 14 and 17, but the former were apparently smaller than those in progeny of control-treated mice. Since adult mice that had cleared the LT[3-R-Ig still lacked LNs even after immunization with antigen in CFA, the interruption of LT signallng during fetal development has irreversible consequences for lymph node formation.
ELISA analyses showed that all three IgG 1 fusion proteins were present but not at equivalent levels in the circulation of the progeny (Table 2 ). To determine that the effect (Table 1) contrasts to their absence in TNF-R55-deficient mice (16) . Although repeated administration of the TNF-R55-Ig has m vivo effects (see the effects of fusion proteins on splenic MAdCAM-1 expression below), and as the TNF-R55-Ig serum level did not persist comparably to that of LT[B-R-Ig fusion protein in the progeny (Table 2) , it is possible that TNF-R55-Ig was not present at sufficient levels to disrupt development of Peyer's patches which occurs after birth.
The selective effect of LT[3-R-Ig treatment could result from its specific engagement of LTot/[3 complexes or its binding to an undefined alternative ligand. Although we cannot yet ascertain if the endogenous LT~-R is the mediating receptor, the role of the LT[3 protein was directly examined. LN development was ablated by gestational treatment with a hamster anti-murine LT~ mAb ( Table 1) in the absence of extrinsic activation on a fetal cell population.
Ordering of LN Development. By varying the gestational day of LT[3-R-Ig injection, the genesis of LNs and Peyer's patches was ordered and shown to be as follows: mesenterics; brachials; axillaries; inguinals and pophteals; Peyer's patches (Table 3 ). This may reflect the extension of the lymphatic and circulatory vasculature during murine ontogeny as peripheral LN development appears to proceed in an anterior-to-posterior order. Interestingly, mesenteric LNs were detected in the progeny of mice that had been treated with LT[3-R-Ig as early as gestational day 9, suggesting that an additional LTot-specific pathway may be involved in the genesis of the mesenteric nodes. Alternatively, effective yolk sac transport may not occur early enough during development to ablate the formation of these nodes. Together with the inability to detect an empty anlage, these data indicate that LT[3-R-Ig binds its specific hgand to influence the development of LNs rather than to obliterate LNs already established during embryogenesis. engagement is not required for their morphogenesis. To probe for more subde effects, histological examinations of the spleens and thymi from treated and control mice were performed. As the spleen is populated with lymphocytes in the weeks after birth, injections of soluble LT[3-1K-Igtreated progeny were continued posmatally (100 p,g once weekly for 5 wk). Histological analyses showed that thymi had clearly defined cortical and medullary zones (data not shown) and that both red and white pulp components are detected in the spleens of LT[3-R-Ig mice treated only during fetal development. However, after multiple LT[3-1K-Ig injections the red and white pulp became disorganized (Fig. 2, A and B) as in LTot -/-mice (9, 10). Moreover, immunohistochemical analyses showed alterations in lymphocyte positioning in the white pulp. Although T cells still appeared to concentrate around the central arterioles, these periarteriolar lymphoid sheaths were reduced in size, the B cells follicles had ragged edges, and T and B cells failed to segregate exclusively into these zones (Fig. 2 F) as in spleens of control mice (Fig. 2 C) . Such lymphocyte disorganization was observed in LTot -/- (Fig. 2 D, and 9, 11) but not in TNF-R55 -/-mice (8) .
Marginal zone cells bounding the T/B regions of the spleens from LTot -/-mice fail to express a characteristic marker, MOMA-1 (8). In our system, the expression of yet another marginal zone marker, MAdCAM-1, was lacking in spleens of mice treated multiple times with LTJ3-R-Ig (Fig. 3 C) or TNF-R55-Ig (data not shown). Similar effects of LTJ3-R-Ig but not TNF-R55-Ig on expression of other marginal zone markers (i.e., sialoadhesin) were also noted (data not shown). When LT[3-R-Ig was introduced only during gestation, relatively minor T and B cell disorganization was noted (Fig. 2 E) , yet marginal zone MAd-CAM-1 expression was diminished (Fig. 3 B) and the size of white pulp islands appears to be reduced (data not shown). This apparent continuum of LTf3-R-Ig splenic effects suggests that continuous interaction of LTcx/[3 with LTJ3-R or an alternative receptor influences the organization of cells in this secondary lymphoid organ.
In this work, we have reproduced most aspects of the phenotype of the LToL -/-mouse (except the absence of mesenteric LNs) by administering sohible LT[3-R-Ig, thus showing that membrane LTot/J3 and not LTot3 signals a specific molecular pathway which controls LN genesis, organization of lymphocytes within splenic follicles, and the integrity of the splenic marginal zone. It will be interesting to determine whether LTot/[3 acts as a master switch directing the expression of cell surface markers (i.e., MAd-CAM-1 or MOMA-1) essential to these processes or controlling other activities of as yet undefined organizing cell types. TNF-R55 -/-mice express MOMA-1 (8) but not MAdCAM-1 (23) in the splenic marginal zones, suggesting that MAdCAM-1 expression on marginal zone cells does not directly correlate with lymphocyte disorganization xn the white pulp. Our data also show reasonable T/B organization when MAdCAM-1 expression is reduced (Figs. 2 E  and 3 B) thus questioning the requirement of this adhesion molecule for splenic lymphocyte organization. Moreover, experiments using toxic liposomes to eliminate MOMA-1 + splenic macrophages also did not show splenic disorganization (24) . The failure of mutant aly mice (25, 26) , relBdeficient mice (27, 28) , and Ikaros knockout mice (29) to develop LNs and the disorganized lymphoid architecture in the spleen of the aly (26) and relB-deficient mice (27, 28) designates roles for other components in these processes. However, our data show that expression of the LT[3 gene, like the Hox11 gene which controls the genesis of the spleen (30) , has a central role in the development of the secondary lymphoid organs in the absence of the immunocompromised phenotype noted m the aly mice, relB, and Ikaros-deficient mice. Moreover, LTcx/[3 is distinct from these transcription factors, representing the first cell surface ligand identified to be critical for such immune morphogenetic processes.
LT[3-R is expressed on reticular dendritic cells in the red pulp of human fetal spleen (30a) and has not been found on T or B lymphocytes. Surface ligand in contrast has been observed only on activated human T and B lymphocytes and NK cells (31) . Contact between trafficking/activated LTot/I3 + lymphocytes and stromal elements such as dendritic cells in peripheral lymphoid organs could facilitate the subsequent positiomng of lymphocytes as in GC formation and thus influence the maturation of the immune response. The absence of such a signal would result in the splenic phenotype and impaired GC formation observed in the LTot knockout mice (8) . As the LTci -/-mice manifest an LTot/[3-phenotype, the role of LToL/[3 in GC formation is under study using the tools described herein. Such a role for membrane LT is also consistent with reports that TNF superfamily members participate in cognate interactions (31, 32) . Impairment of CD40/CD40L interactions causes profound immunodeficiency (33) , and disruption of either the CD40/CD40L interaction or the TNF-P,.55 or LTci genes contributes to the failure to form GC (38). As CD40 ligation induces expression of LTot/[3 complexes on B cells (35, and Hochman, P., unpublished data), CD40 and surface LT may represent steps in a linear sequence of events. Alternatively, since both CD40 and LT[3-R share a cytoplasmic signal transduction element, TRAF-3 (36), these pathways may have interdependent roles in the formanon and maintenance of GC.
Finally, this report documents a technique that disrupts a discrete developmental pathway without the need for genetic manipulation. Taken together with the Hox11 knockout (30) , this strategy can generate powerful models to evaluate the compartmentahzation of the immune system. Since soluble receptors can be introduced at specific points in ontogeny, the approach shown herein can order developmental events and facilitate the study of multifunctional pathways where genetic disruption has led to a lethal phenotype, as in the case of ablation of the oL4 integrin gene (37) .
